Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (53)

2024

  1. Enhancing patient outcomes: Integrating electronic cardiology consultation in primary care for cancer patients

    European Journal of Clinical Investigation, Vol. 54, Núm. 8

2023

  1. Current professional standing of young medical oncologists in Spain: a nationwide survey by the Spanish Society of Medical Oncology + MIR section

    Clinical and Translational Oncology, Vol. 25, Núm. 3, pp. 796-802

  2. Dual neoadjuvant blockade plus chemotherapy versus monotherapy for the treatment of women with non-metastatic HER2-positive breast cancer: a systematic review and meta-analysis

    Clinical and Translational Oncology, Vol. 25, Núm. 4, pp. 941-958

  3. Erratum: Personalized Precision Medicine for Health Care Professionals: Development of a Competency Framework (JMIR Medical Education (2023) 9 (e43656) DOI: 10.2196/43656)

    JMIR Medical Education

  4. Personalized Precision Medicine for Health Care Professionals: Development of a Competency Framework

    JMIR Medical Education, Vol. 9

2022

  1. Identification of Thrombosis-Related Genes in Patients with Advanced Gastric Cancer: Data from AGAMENON-SEOM Registry

    Biomedicines, Vol. 10, Núm. 1

  2. Methods for the Detection of Circulating Biomarkers in Cancer Patients

    Advances in experimental medicine and biology, Vol. 1379, pp. 525-552

  3. Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study

    European Journal of Cancer, Vol. 168, pp. 12-24

2021

  1. Cancer epigenetic biomarkers in liquid biopsy for high incidence malignancies

    Cancers, Vol. 13, Núm. 12

  2. Do clinical trials meet current care needs? Views of digestive oncology specialists in galicia (spain) using the delphi method

    Healthcare (Switzerland), Vol. 9, Núm. 6

  3. Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor–positive metastatic breast cancer: Patient-reported outcomes in the PEARL study

    European Journal of Cancer, Vol. 156, pp. 70-82

  4. Immunotherapy in nonsmall-cell lung cancer: current status and future prospects for liquid biopsy

    Cancer Immunology, Immunotherapy, Vol. 70, Núm. 5, pp. 1177-1188

  5. Letter to the editor: “Liquid biopsy based on saliva cell-free DNA as a potential biomarker for head and neck cancer”

    Oral Oncology

  6. Saliva gene promoter hypermethylation as a biomarker in oral cancer

    Journal of Clinical Medicine, Vol. 10, Núm. 9

  7. Salivary dna methylation as an epigenetic biomarker for head and neck cancer. Part i: A diagnostic accuracy meta-analysis

    Journal of Personalized Medicine, Vol. 11, Núm. 6

  8. Salivary dna methylation as an epigenetic biomarker for head and neck cancer. Part ii: A cancer risk meta-analysis

    Journal of Personalized Medicine, Vol. 11, Núm. 7

  9. Trajectories of alcohol consumption during life and the risk of developing breast cancer

    British Journal of Cancer, Vol. 125, Núm. 8, pp. 1168-1176

2020

  1. Association of salivary human papillomavirus infection and oral and oropharyngeal cancer: A meta-analysis

    Journal of Clinical Medicine, Vol. 9, Núm. 5

  2. Circulating Extracellular Vesicles in Gynecological Tumors: Realities and Challenges

    Frontiers in Oncology, Vol. 10

  3. Global gene expression characterization of circulating tumor cells in metastasic castration-resistant prostate cancer patients

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-14